Literature DB >> 15549470

Amsorb Plus and Drägersorb Free, two new-generation carbon dioxide absorbents that produce a low compound A concentration while providing sufficient CO2 absorption capacity in simulated sevoflurane anesthesia.

Shunji Kobayashi1, Hiromichi Bito, Koji Morita, Takasumi Katoh, Shigehito Sato.   

Abstract

PURPOSE: The properties of two new-generation CO(2) absorbents, Amsorb Plus (Armstrong Medical, Coleraine, UK) and Drägersorb Free (Drager, Lubeck, Germany), were compared with those of Amsorb (Armstrong Medical) and Sodasorb II (W.R. Grace, Lexington, MA, USA).
METHODS: The concentration of compound A produced by each absorbent was determined in a low-flow circuit containing sevoflurane, and the CO(2) absorption capacity of the absorbent was measured. The circuit contained 1000 g of each absorbent and had a fresh gas (O(2)) flow rate of 1 l.min(-1) containing 2% sevoflurane. CO(2) was delivered to the circuit at a flow rate of 200 ml.min(-1).
RESULTS: The maximum concentrations of compound A were 2.2 +/- 0.0, 2.3 +/- 0.3, 2.2 +/- 0.2, and 23.5 +/- 1.5 ppm (mean +/- SD) for Amsorb Plus, Drägersorb Free, Amsorb, and Sodasorb II, respectively. The maximum concentration of compound A for Sodasorb II was significantly higher than those for the other absorbents (P < 0.01). The CO(2) absorption capacities (time taken to reach an inspiratory CO(2) level of 2 mmHg) were 1023 +/- 48, 1074 +/- 36, 767 +/- 41, and 1084 +/- 54 min, respectively, and the capacity of Amsorb was significantly lower than that of the other absorbents (P < 0.01).
CONCLUSION: The new-generation carbon dioxide absorbents, Amsorb Plus and Drägersorb Free, produce a low concentration of compound A in the circuit while showing sufficient CO(2) absorption capacity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549470     DOI: 10.1007/s00540-004-0253-5

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  2 in total

1.  Performance of a new carbon dioxide absorbent, Yabashi lime® as compared to conventional carbon dioxide absorbent during sevoflurane anesthesia in dogs.

Authors:  Kei Kondoh; Ayman Atiba; Kiyoshi Nagase; Shizuko Ogawa; Takashi Miwa; Teruya Katsumata; Hiroshi Ueno; Yuji Uzuka
Journal:  J Vet Med Sci       Date:  2015-05-04       Impact factor: 1.267

2.  Predicting cost of inhalational anesthesia at low fresh gas flows: impact of a new generation carbon dioxide absorbent.

Authors:  Alastair E Moody; Bryce D Beutler; Catriona E Moody
Journal:  Med Gas Res       Date:  2020 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.